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Abstract
Background: Providing quantitative microarray data that is sensitive to very small differences in
target sequence would be a useful tool in any number of venues where a sample can consist of a
multiple related sequences present in various abundances. Examples of such applications would
include measurement of pseudo species in viral infections and the measurement of species of
antibodies or T cell receptors that constitute immune repertoires. Difficulties that must be
overcome in such a method would be to account for cross-hybridization and for differences in
hybridization efficiencies between the arrayed probes and their corresponding targets. We have
used the memory T cell repertoire to an influenza-derived peptide as a test case for developing
such a method.
Results: The arrayed probes were corresponded to a 17 nucleotide TCR-specific region that
distinguished sequences differing by as little as a single nucleotide. Hybridization efficiency between
highly related Cy5-labeled subject sequences was normalized by including an equimolar mixture of
Cy3-labeled synthetic targets representing all 108 arrayed probes. The same synthetic targets were
used to measure the degree of cross hybridization between probes. Reconstitution studies found
the system sensitive to input ratios as low as 0.5% and accurate in measuring known input
percentages (R2 = 0.81, R = 0.90, p < 0.0001). A data handling protocol was developed to
incorporate the differences in hybridization efficiency. To validate the array in T cell repertoire
analysis, it was used to analyze human recall responses to influenza in three human subjects and
compared to traditional cloning and sequencing. When evaluating the rank order of clonotype
abundance determined by each method, the approaches were not found significantly different
(Wilcoxon rank-sum test, p > 0.05).
Conclusion: This novel strategy appears to be robust and can be adapted to any situation where
complex mixtures of highly similar sequences need to be quantitatively resolved.
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Background
Over the past decade, microarrays have evolved beyond
high-throughput gene expression profiling to a wide vari-
ety of applications that include genotyping and rese-
quencing. Even more diverse are the biological venues
where these new developments have been applied. This
report describes a novel array-based assay that accurately
identifies and quantifies nucleotide sequences that share
extensive identity. Such an approach has numerous appli-
cations including human leukocyte antigen (HLA) sys-
tem, viral or bacterial genotyping, characterization
microbial species within environmental samples, or as
described here, the measurement of pathogen specific
human memory T-cell repertoire diversity.
During the initiation of immune responses, individual T-
cell clones recognize peptides presented by major histo-
compatibility complex (MHC) molecules through T-cell
receptors (TCR). TCRs are heterodimers consisting of
either α and β chains or γ and δ chains. Each chain is com-
posed of variable (V), diversity (D, β and δ chains), join-
ing (J), and constant (C) regions encoded by gene
segments that undergo rearrangement during thymic T-
cell development [1]. The shape and charge, and therefore
TCR specificity is determined by the selection of the V, D
and J genes, as well as the rearrangement process itself
where nucleotides at junctions of the V, D, and J segments
are added or removed. The portion of the TCR encoded at
the rearrangement site is referred to as the third comple-
mentarity-determining region (CDR3). Any rearrange-
ment utilizing the same V and J genes is identical except
for the unique nucleotide sequence of the CDR3. This
sequence is considered to define a clonotype and serves as
a fingerprint for the T-cell lineage bearing it. The fre-
quency with which a particular TCR clonotype is encoun-
tered can be taken to be a measure of clonal expansion.
The amino acid sequence encoded by CDR3 conveys fine
antigen specificity. Often recognition of a particular anti-
gen-MHC complex is mediated by TCR using identical V
chains with very similar CDR amino acid sequences
(reviewed in [2]). Because of the degeneracy of the genetic
code this can lead to responses characterized by multiple
clonotypes that encode identical CDR3 amino acid
sequences.
Since antigen specific T-cell responses are central to
human immunity, and there is significant interest in the
relationship between lymphocyte diversity and immuno-
competence, the analysis of T-cell repertoires is highly rel-
evant [3,4]. An individual α/β repertoire consists of an
estimated 106  β chains, each pairing with a limited
number of α chains, thus the complexity of the TCR
makes analysis cumbersome [1,5,6]. Molecular genetic
approaches have been developed for analysis of TCR rep-
ertoires that involve amplification of cDNA using C and V
specific primers, or genomic DNA between V and J specific
primers, followed by separation of PCR products through
denaturing gel electrophoresis. This approach, termed
spectratyping, provides an estimation of the abundance of
a particular V gene family relative to others as well as the
different TCR based on their CDR3 length [7-10]. The
highest resolution method for measuring and identifying
T-cells within repertoires is to generate sequences of the
CDR3. This is known as clonotyping and can be accom-
plished by using PCR to amplify variable families from
cDNA followed by sub-cloning and sequencing the prod-
uct to study repertoire structure [8]. Such approaches have
been found to give an unbiased measurement of TCR
diversity [11].
We have been studying the cytotoxic memory T-cell
response to influenza virus [8,12-14]. The M1-derived
epitope, M158–66, an immunodominant peptide derived
from influenza A virus, induces a strong CD8 T-cell
response in HLA-A2 individuals [3,4]. M158–66 bound to
HLAA2.1 (M1-A2) is preferentially recognized by CD8 T-
cells expressing β variable 17 chains (VB17) rearranged to
JB2.7 chains and possessing CDR3 regions with an "IRSS"
amino acid motif. We have also observed that the memory
repertoires are complex consisting of a few clonotypes
observed often, many clonotypes observed once and oth-
ers present in intermediate abundances. Such complexity
in memory repertoires implies a selection for multiple T-
cell lineages and belies a simple selection process. We
have already shown that different clonotypes may be
needed at different stages in an immune response relative
to pathogen density [12]. Further work is required to
study how this repertoire complexity changes with time,
exposure to pathogen or immunization in a population of
HLA-A2 individuals.
In cases such as this, where a complex repertoire exhibits
an identified, highly prevalent CDR3 amino acid motif,
with individual clonotypes observed at different frequen-
cies, an alternate high resolution approach to sub cloning
and sequencing of family specific TCR VB PCR products
would be to generate microarrays that represent all possi-
ble encoding of a particular motif. Such an approach
would enable a rapid, high-throughput measurement of
clontypic diversity at the nucleotide level, thereby facili-
tating population-based studies aimed at better under-
standing the processes of memory repertoire selection.
Described here is a microarray assay that accurately iden-
tifies and quantifies T-cell repertoires for VB17 – JB2.7
rearrangements possessing IRSS as the core amino acid
sequence. Because the final serine in the motif is often
encoded by the J region gene, the actual number of possi-
bilities encoding most encountered IRSS motifs is 108 (3
× 6 × 6).BMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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The described assay represents the foundation of an
expanding system to quantitatively measure a broader
range of the memory repertoire that greatly simplifies the
process of sampling immune repertoires in large popula-
tions over time. This specific application is directly rele-
vant to laboratories investigating T-cell receptor usage,
however, the overall strategy is applicable for quantitative
genotyping of any complex mixture or highly polymor-
phic system where the constituent sequences differ by
only one or a few nucleotides.
Results
Previously, we observed that T-cells of HLA-A2 individu-
als responding to influenza M1 peptide utilized TCR rear-
rangements between the JB2.7 and VB17 gene families
possessing CDR3 regions encoding an "IRSS" amino acid
motif [12]. Therefore, our goal was to develop an oligonu-
cleotide based-microarray for typing the presence and
abundance of 108 CDR3β sequences encoding IRSS as the
core amino acid motif. These 108 clonotypic sequences
from VB17 – JB2.7 expressing T cells account for 21.7% of
the memory repertoire in 40 individuals analyzed thus far.
The assay design is illustrated in Figure 1. The array is
comprised of 108 63-mer probes. The probes were
designed with a 23 nucleotide 5'-region specific for the
Arabidopsis thaliana LTP4 gene; a 23 nucleotide polyA
spacer, and a 17 nucleotide IRSS-specific region (sense
strand) placed at the 3'-end of the probe. The A. thaliana
specific region offers advantages in terms of quality con-
trol. First, it makes possible the hybridization of a single
labeled complementary A. thaliana synthetic target to all
elements of the array (Figure 2A). Second, since oligonu-
cleotides are synthesized in a 3'→5' direction, robust A.
thaliana signal provides control to the synthesis quality of
the more important 3' CDR3β-specific region. This
approach, combined with the use of a labeled tracking oli-
gonucleotide that is co-spotted with the analyte-specific
63-mers [15], provides control of both probe synthesis
and array fabrication.
Specificity of 108 IRSS-specific CDR3β probes
Specificity is a major issue in any genotyping assay. Previ-
ously, we have found short oligonucleotides useful in
resolving alleles sharing extensive identity [16,17]. Thus,
we empirically optimized the length of the CDR3β-spe-
cific probe region to 17 nucleotides (data not shown). In
order to test the specificity of each of the 108 probes, com-
plementary synthetic targets (73-mers) were designed to
precisely mimic the anti-sense strand of RT-PCR products
generated by the VB17 and JB2.7-specific oligonucleotide
primers used for clonotyping.
The 108 IRSS clonotype sequences possess high degrees of
identity, with any single clonotype differing by only one
or a few nucleotides from any other (Table 1). Thus, the
degree of cross-hybridization and its potential impact on
identifying and quantifying specific CDR3β sequences
was investigated. In general the measured intensity (Mi )
of a probe i can be written as:
MI I ii i j j
ji
=+ ⋅
≠
∑ α (1)
Hybridization of CDR3β-specific microarrays Figure 2
Hybridization of CDR3β-specific microarrays. Panel A. Cy3/
FITC overlay image of Cy3-labeled A. thaliana LTP4 synthetic 
target (red) hybridized to 108 CDR3β-specific probes. Black 
arrows indicate negative controls, printing buffer with FITC-
labeled tracking oligonucleotide (green) but no CDR3β-spe-
cific probe. Panel B. Cy3/FITC overlay image of Cy3-labeled 
IRSS clonotype 21 synthetic target (red, indicated by white 
arrow) hybridized to 108 CDR3β-specific probes. Outer col-
umns of each subarray are negative controls. Note hybridiza-
tion specificity.
a.
b.
Schematic of overall assay design Figure 1
Schematic of overall assay design. Briefly human cDNA is 
amplified in a non saturating PCR reaction possessing VB17 
and Cy-5 labeled JB2.7-specific primers. Purified PCR prod-
ucts are combined with an equimolar mix of synthetic targets 
complementary to all 108 IRSS-specific CDR3β probes on 
the array and hybridized, washed and analyzed. Probe design 
is illustrated at the bottom of the figure.
CCAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGAGCTCCTACGAGCAGTACTTCGGGCCG
I    R    S   S
VB17-specific forward 
Cy5-JB2.7-specific reverse 
RT-PCR Cy5-IRSS
PCR Product
Cy3-synthetic 
target mix
mix and hybridize 
5’-GAAGAGTATGGTTTCGTATACGT AAAAAAAAAAAAAAAAAAAAAAA  GTAGTATTAGGAGCTCC-3’
IRSS clonotype 1 probe
(Arabidopsis thaliana LTP4) (poly-A) CDR3βBMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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where  αij is a factor that measures the degree of cross
hybridization from probe j and Ii is the intensity of probe
i when there is no cross hybridization (i.e. αij = 0 for all
j≠i). To quantitatively evaluate cross hybridization (A =
(αij)), each of the 108 synthetic targets were independ-
ently hybridized to printed slides possessing 9 replicate
arrays. Figure 2B illustrates such a hybridization. On each
array (k), we expect all probe intensities to be zero (Ii = 0
for all i ≠ k) except the probe (k) for which corresponding
synthetic target has been introduced. Thus, αi,k  was
obtained for all i, k. This is represented by the color-map
illustrated in Figure 3A. Although the specific hybridiza-
tion of each synthetic target is clearly evident, variable
degrees of cross hybridization existed between some syn-
thetic target:probe combinations. We examined the
dependence of cross hybridization (αij) on the number of
nucleotide differences between the possible synthetic tar-
get:probe pairs. Such pairs constituted 6.8% of all possi-
ble pairings (393/5886), and as expected cross
hybridization primary arose from pairs that differed by a
single nucleotide (Figure 3B). However, among all pairs
that possess a single nucleotide difference, there is exten-
sive heterogeneity in their cross hybridization, as evi-
denced by the large standard deviation.
When hybridizing known mixtures of synthetic target to
the CDR3β array, we found that the resulting measured
intensities did not correlate with the known input ratios.
We have attributed this lack of linearity to differences in
hybridization efficiency between the different IRSS encod-
ing sequences, despite their high overall homlogy.
Although the signal derived from a cohybridized A. thal-
iana synthetic target is useful for array quality control,
using it to normalize potentially different amounts of sup-
port-bound probe between spots did not improve the
overall correlation of reconstitution experiments (data
not shown), lending support to the lack of linearity aris-
ing from differences in hybridization efficiency. Thus, we
designed a dual hybridization format where the signals of
an equimolar mixture of all 108 Cy3-labeled targets are
used to normalize the Cy5-labeled CDR3β RT-PCR
patient/subject signal (Figure 1). Since the normalizing
mixture possesses all synthetic targets at an equal molar
concentration, we would expect their intensity to be I1 = I2
= ... = I108 = I0, where I0 is a constant and their measured
intensity to be:
In figure 3C the expected ( ) and measured inten-
sities for all synthetic targets are plotted where a linear
relationship (r = 0.68, p < 0.001) is observed.
MI I ii j j
j
ij
j
norm, ==
==
∑∑ αα
1
108
0
1
108
(3)
α ij
j
I
=
∑
1
108
0
Analysis of each synthetic target hybridized independently to  assess cross-hybridization Figure 3
Analysis of each synthetic target hybridized independently to 
assess cross-hybridization. Panel A. Color map of independ-
ent hybridizations. Each column (x-axis) represents a slide to 
which a single synthetic target was hybridized (1–108). Each 
row (y-axis) represents a clonotype specific probe (1–108). 
Self-hybridization is normalized to 1. Panel B. The degree of 
cross hybridization is plotted against the number of nucle-
otide differences between probe:synthetic target pairs. 
Cross-hybridization arises from probe:synthetic target pairs 
that differ by one base. Panel C. Comparison of the meas-
ured normalizer intensity versus their expected profile. A 
good linear relationship is evident with R = 0.68, p < 0.001.
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Evaluation of assay quantitativeness through 
reconstitution studies
To evaluate the ability of the assay to accurately identify
and quantify different CDR3β sequences within a com-
plex mixture, reconstitution studies were performed. To
avoid purchasing two sets of synthetic targets, these vali-
dation experiments were conducted in a single color for-
mat (Cy3), with the normalizing equimolar mixture of all
108 synthetic targets hybridized to separate slides (n = 5).
Twenty six unique test mixtures were prepared where 6 to
30 different synthetic targets (mean 16.6 +/- 7.4) were
introduced at percentages of 0.5% to 48.82%. The test
mixtures possessed 1 to 5 total picomoles of synthetic tar-
get. Within the 26 mixtures, each of the 108 clonotypes
was measured at least 3 times at 3 different input percent-
ages. Each test mixture was analyzed through hybridiza-
tion to 9 to 18 replicates arrays.
In each of the 26 mixes, the actual clonotype abundances
were closely captured by measured abundances. The
results of representative mixes are shown in Figure 4A–B.
We found the system sensitive to input percentages as low
as 0.5%. The data from all 26 mixes was collectively ana-
lyzed (Figure 4C). Despite some under estimation of high
input percentages and some over estimation of low input
percentages, good agreement between known input per-
centages and measured percentages was observed (R =
0.90, p < 0.0001). Overall, we observed intra and inter-
slide variances of 3.0 and 3.7%, respectively. The data
were examined to determine if any probe consistently
over or under-measured its corresponding input percent-
age and no biases were detected (data not shown). As
reflected in Figures 4A and 4B reliable measured percent-
ages were observed within mixes down to the 2–3% input
level, below which false-positive calls were detected.
Therefore the false discovery rate (FDR)[18] which was
defined as fraction of clonotypes that reached the detec-
tion limit that were not introduced into the test mixture,
at different detection sensitivities was examined. At a
detection sensitivity of 4% or higher, the FDR was equal
to 0. At detection sensitivities between 3% and 1%, the
FDR ranged from 2.3% to 13%, respectively.
Analysis of M158–66/HLA-A2.1-specific CD8 T-cell 
cultures by traditional clonotyping and array analysis
To validate the array in T-cell repertoire analysis, it was
used to analyze human recall responses to influenza
M158–66 restricted by HLA-A2. Three human subjects were
analyzed (designated A, B, and C in Tables 2, 3, and 4,
respectively). In each case triplicate T-cell cultures were
propagated (designated 1, 2, and 3 for each subject) then
analyzed by microarray and traditional clonotyping.
Short term recall cultures are a standard assay for increas-
ing the frequency of antigen-specific clonotypes in the
sample. This occurs because the specific T cells expand
and some of the non-specific T cells die out in the cultures.
Cultures are performed in triplicate to control for the var-
iation that arises in a complex biological response in vitro.
RNA extracted from each culture was reverse transcribed,
and amplified with forward and reverse primers targeting
the VB17 and JB2.7 segments, respectively. In the case of
the microarray analysis, the product was amplified with
Assessment of assay performance through oligonucleotide  reconstitution studies Figure 4
Assessment of assay performance through oligonucleotide 
reconstitution studies. Panels A and B: Known input percent-
ages are indicated (grey, total 100%), measured percentages 
are indicated in black. Clonotype number is indicated on x-
axis, arranged by descending measured percentage. All meas-
ured percentages are shown to the level of the lowest input 
percentage. Panel C: Summary plot of the 26 reconstitution 
mixes representing all 108 clonotypes. Dotted line shows 
correlation between input and measured percentages (R = 
0.90, p < 0.0001, log10M = 100.68 *log10I + 0.28). A 45° refer-
ence line (solid) is shown.
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Cy5 labeled JB2.7 primer, purified and hybridized, as
illustrated in Figure 1. With the traditional approach,
unlabeled product was cloned into a plasmid vector,
transformed into Escherichia coli, plated, and 188 colo-
nies per culture (564 colonies per subject) were sequenced
to establish clonal diversity.
In the reconstitution studies, we determined that at a sen-
sitivity of detection ≥ 4% the FDR was equal to 0. When
comparing the microarray data to traditional clonotyping
under these strictest standards (ie a clonotype must be
detected within at least 1 culture at ≥ 4% abundance in the
array analysis), we observe that on average, the array
Table 1: Partial probe and synthetic target sequences
IRSS Probe* Synthetic Target** IRSS Probe* Synthetic Target**
1 -GTAGTATTAGGAGCTCC-3' -GGAGCTCCTAAT- 55 -GTAGTATCCGCTCCTCC-3' -GGAGGAGCGGAT-
2 -GTAGTATAAGGAGCTCC-3' -GGAGCTCCTTAT- 56 -GTAGTATTCGATCCTCC-3' -GGAGGATCGAAT-
3 -GTAGTATAAGAAGCTCC-3' -GGAGCTTCTTAT- 57 -GTAGTATCCGATCCTCC-3' -GGAGGATCGGAT-
4 -GTAGTATCAGGAGCTCC-3' -GGAGCTCCTGAT- 58 -GTAGTATTCGGTCCTCC-3' -GGAGGACCGAAT-
5 -GTAGTATTAGAAGCTCC-3' -GGAGCTTCTAAT- 59 -GTAGTATCCGGTCCTCC-3' -GGAGGACCGGAT-
6 -GTAGTATTCGTAGCTCC-3' -GGAGCTACGAAT- 60 -GTAGTATTAGGAGTTCC-3' -GGAACTCCTAAT-
7 -GTAGTATCCGCAGCTCC-3' -GGAGCTGCGGAT- 61 -GTAGTATCAGGAGTTCC-3' -GGAACTCCTGAT-
8 -GTAGTATAAGGTCCTCC-3' -GGAGGACCTTAT- 62 -GTAGTATTAGAAGTTCC-3' -GGAACTTCTAAT-
9 -GTAGTATAAGATCCTCC-3' -GGAGGATCTTAT- 63 -GTAGTATCAGAAGTTCC-3' -GGAACTTCTGAT-
10 -GTAGTATACGTAGCTCC-3' -GGAGCTACGTAT- 64 -GTAGTATTAGGTCTTCC-3' -GGAAGACCTAAT-
11 -GTAGTATACGCAGCTCC-3' -GGAGCTGCGTAT- 65 -GTAGTATCAGGTCTTCC-3' -GGAAGACCTGAT-
12 -GTAGTATACGAAGCTCC-3' -GGAGCTTCGTAT- 66 -GTAGTATTAGATCTTCC-3' -GGAAGATCTAAT-
13 -GTAGTATACGGAGCTCC-3' -GGAGCTCCGTAT- 67 -GTAGTATCAGATCTTCC-3' -GGAAGATCTGAT-
14 -GTAGTATACGTTCCTCC-3' -GGAGGAACGTAT- 68 -GTAGTATTCGTAGTTCC-3' -GGAACTACGAAT-
15 -GTAGTATACGCTCCTCC-3' -GGAGGAGCGTAT- 69 -GTAGTATCCGTAGTTCC-3' -GGAACTACGGAT-
16 -GTAGTATACGATCCTCC-3' -GGAGGATCGTAT- 70 -GTAGTATTCGCAGTTCC-3' -GGAACTGCGAAT-
17 -GTAGTATACGGTCCTCC-3' -GGAGGACCGTAT- 71 -GTAGTATCCGCAGTTCC-3' -GGAACTGCGGAT-
18 -GTAGTATAAGGAGTTCC-3' -GGAACTCCTTAT- 72 -GTAGTATTCGAAGTTCC-3' -GGAACTTCGAAT-
19 -GTAGTATAAGAAGTTCC-3' -GGAACTTCTTAT- 73 -GTAGTATCCGAAGTTCC-3' -GGAACTTCGGAT-
20 -GTAGTATAAGGTCTTCC-3' -GGAAGACCTTAT- 74 -GTAGTATTCGGAGTTCC-3' -GGAACTCCGAAT-
21 -GTAGTATAAGGTCATCC-3' -GGATGACCTTAT- 75 -GTAGTATCCGGAGTTCC-3' -GGAACTCCGGAT-
22 -GTAGTATAAGGTCGTCC-3' -GGACGACCTTAT- 76 -GTAGTATTCGTTCTTCC-3' -GGAAGAACGAAT-
23 -GTAGTATAAGATCTTCC-3' -GGAAGATCTTAT- 77 -GTAGTATCCGTTCTTCC-3' -GGAAGAACGGAT-
24 -GTAGTATAAGATCATCC-3' -GGATGATCTTAT- 78 -GTAGTATTCGCTCTTCC-3' -GGAAGAGCGAAT-
25 -GTAGTATAAGATCGTCC-3' -GGACGATCTTAT- 79 -GTAGTATCCGCTCTTCC-3' -GGAAGAGCGGAT-
26 -GTAGTATACGTAGTTCC-3' -GGAACTACGTAT- 80 -GTAGTATTCGATCTTCC-3' -GGAAGATCGAAT-
27 -GTAGTATACGCAGTTCC-3' -GGAACTGCGTAT- 81 -GTAGTATCCGATCTTCC-3' -GGAAGATCGGAT-
28 -GTAGTATACGAAGTTCC-3' -GGAACTTCGTAT- 82 -GTAGTATTCGGTCTTCC-3' -GGAAGACCGAAT-
29 -GTAGTATACGGAGTTCC-3' -GGAACTCCGTAT- 83 -GTAGTATCCGGTCTTCC-3' -GGAAGACCGGAT-
30 -GTAGTATACGTTCATCC-3' -GGATGAACGTAT- 84 -GTAGTATTAGGTCATCC-3' -GGATGACCTAAT-
31 -GTAGTATACGTTCGTCC-3' -GGACGAACGTAT- 85 -GTAGTATCAGGTCATCC-3' -GGATGACCTGAT-
32 -GTAGTATACGTTCTTCC-3' -GGAAGAACGTAT- 86 -GTAGTATTAGATCATCC-3' -GGATGATCTAAT-
33 -GTAGTATACGCTCATCC-3' -GGATGAGCGTAT- 87 -GTAGTATCAGATCATCC-3' -GGATGATCTGAT-
34 -GTAGTATACGCTCGTCC-3' -GGACGAGCGTAT- 88 -GTAGTATTCGTTCATCC-3' -GGATGAACGAAT-
35 -GTAGTATACGATCTTCC-3' -GGAAGATCGTAT- 89 -GTAGTATCCGTTCATCC-3' -GGATGAACGGAT-
36 -GTAGTATACGATCATCC-3' -GGATGATCGTAT- 90 -GTAGTATTCGCTCATCC-3' -GGATGAGCGAAT-
37 -GTAGTATACGATCGTCC-3' -GGACGATCGTAT- 91 -GTAGTATCCGCTCATCC-3' -GGATGAGCGGAT-
38 -GTAGTATACGGTCTTCC-3' -GGAAGACCGTAT- 92 -GTAGTATTCGATCATCC-3' -GGATGATCGAAT-
39 -GTAGTATACGGTCATCC-3' -GGATGACCGTAT- 93 -GTAGTATCCGATCATCC-3' -GGATGATCGGAT-
40 -GTAGTATACGGTCGTCC-3' -GGACGACCGTAT- 94 -GTAGTATTCGGTCATCC-3' -GGATGACCGAAT-
41 -GTAGTATCAGAAGCTCC-3' -GGAGCTTCTGAT- 95 -GTAGTATCCGGTCATCC-3' -GGATGACCGGAT-
42 -GTAGTATTAGGTCCTCC-3' -GGAGGACCTAAT- 96 -GTAGTATTAGGTCGTCC-3' -GGACGACCTAAT-
43 -GTAGTATCAGGTCCTCC-3' -GGAGGACCTGAT- 97 -GTAGTATCAGGTCGTCC-3' -GGACGACCTGAT-
44 -GTAGTATTAGATCCTCC-3' -GGAGGATCTAAT- 98 -GTAGTATTAGATCGTCC-3' -GGACGATCTAAT-
45 -GTAGTATCAGATCCTCC-3' -GGAGGATCTGAT- 99 -GTAGTATCAGATCGTCC-3' -GGACGATCTGAT-
46 -GTAGTATCCGTAGCTCC-3' -GGAGCTACGGAT- 100 -GTAGTATTCGTTCGTCC-3' -GGACGAACGAAT-
47 -GTAGTATTCGCAGCTCC-3' -GGAGCTGCGAAT- 101 -GTAGTATCCGTTCGTCC-3' -GGACGAACGGAT-
48 -GTAGTATTCGAAGCTCC-3' -GGAGCTTCGAAT- 102 -GTAGTATTCGCTCGTCC-3' -GGACGAGCGAAT-
49 -GTAGTATCCGAAGCTCC-3' -GGAGCTTCGGAT- 103 -GTAGTATCCGCTCGTCC-3' -GGACGAGCGGAT-
50 -GTAGTATTCGGAGCTCC-3' -GGAGCTCCGAAT- 104 -GTAGTATTCGATCGTCC-3' -GGACGATCGAAT-
51 -GTAGTATCCGGAGCTCC-3' -GGAGCTCCGGAT- 105 -GTAGTATCCGATCGTCC-3' -GGACGATCGGAT-
52 -GTAGTATTCGTTCCTCC-3' -GGAGGAACGAAT- 106 -GTAGTATTCGGTCGTCC-3' -GGACGACCGAAT-
53 -GTAGTATCCGTTCCTCC-3' -GGAGGAACGGAT- 107 -GTAGTATCCGGTCGTCC-3' -GGACGACCGGAT-
54 -GTAGTATTCGCTCCTCC-3' -GGAGGAGCGAAT- 108 -GTAGTATACGCTCTTCC-3' -GGAAGAGCGTAT-
* Entire probe sequence: 5'-GAA GAG TAT GGT TTC GTA TAC GTA AAA AAA AAA AAA AAA AAA AAA AXX XXX XXX XXX XXX XXX-3' (X represents tabulated 
probe sequence for clonotypes 1–108)
**Entire synthetic target sequence: Cy3–5'-CGG CCC GAA GTA CTG CTC GTA XXX XXX XXX XXX ACT ACT GGC ACA GAG ATA GAA AGC TGT CGG GTT 
CTT TTG G-3' (X represents tabulated synthetic target sequence for clonotypes 1–108)BMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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detects slightly more clonotypes than does cloning and
sequencing (1.1-fold more: 42 versus 37; subject A: 13
versus 12; subject B: 7 versus 14; subject C: 22 versus 12).
In subject A, the array detected 2 clonotypes not observed
by cloning, while cloning identified 1 clonotype not
observed by the array. In subject B, the array detected 1
clonotype not observed by cloning, while cloning
detected 8 clonotypes not observed by the array. In subject
C, the array detected 16 clonotypes not observed by clon-
ing, while cloning identified 6 clonotypes not observed by
the array.
If the data is examined using a 1% sensitivity of detection
(FDR = 13%) the total number of clonotypes detected the
by array analysis among the three subjects increases from
42 to 68. This increased sensitivity of 26 additional clono-
types would be predicted to include approximately 3 false
positives. At this stringency, the array detected nearly
twice as many clonotypes than did cloning/sequencing
(1.8-fold more: 68 versus 37; culture A: 19 versus 11; cul-
ture B: 20 versus 14; culture C: 29 versus 12). In analysis
A, the array detected 9 clonotypes not observed by clon-
ing, while cloning identified 1 clonotype not observed by
the array. In analysis B, the array detected 8 clonotypes not
observed by cloning, while cloning detected 2 clonotypes
not observed by the array. In analysis C, the array detected
22 clonotypes not observed by cloning, while cloning
identified 5 clonotypes not observed by the array.
Among subjects A, B and C there were respectively 10, 12,
and 7 clonotypes commonly detected by the array and
cloning/sequencing. When evaluating the rank order of
clonotype abundance determined by each method, the
approaches are not significantly different (Wilcoxon rank-
sum test, p > 0.05).
Discussion
In this report, we describe a spotted oligonucleotide
microarray application for the investigation of cytotoxic
memory T-cell repertoires against influenza matrix pro-
tein, M158–66  in HLA-A2 individuals. This expandable
approach specifically identifies 108 highly related CDR3β
sequences that encode the IRSS core amino acid motif and
accurately quantifies their relative abundances within a
complex mixture. The design, development, and use of
this assay depended on the use of novel strategies to con-
trol for array fabrication variables and vendor oligonucle-
otide synthesis quality, as well as to normalize differences
in hybridization efficiencies between the closely related
target sequences.
The microarray application described here is unlike most
array assays. Typically, the arrayed probes represent up to
tens of thousands of independent parallel assays, where
each probe measures the relative abundance of a single
distinct gene among the samples being compared. In this
Table 3: Comparison of array based clonotyping to cloning and 
sequencing of PCR products: Subject B
Array analysis Cloning/sequencing
Clono
type
1 2 3 Mean (SD) 1 2 3 Mean (SD)
50 6
1
4
5
7
0
58.6 (+/-
12.5)
4
6
2
4
0 23.2 (+/-23)
41
1
2
5
1
1
15.5 (+/-7.8) 3
0
5
3
36 39.8 (+/-11.7)
13 0 1
2
76 . 3 ( + / - 5 . 9 )31
4
11 9.1 (+/-5.4)
64 1
2
305 . 0 ( + / - 6 . 3 )310 1 . 3 ( + / - 1 . 6 )
94 7 8 0 4.9 (+/-4.3) 6 7 1 4.9 (+/-3.1)
83 0 0 5 1.7 (+/-2.9) 0 0 0 0 (+/-0)
11 5 0 0 1.7 (+/-2.9) 5 0 0 1.8 (+/-3.2)
1 0221 . 3 ( + / - 1 . 1 )200 0 . 5 ( + / - 0 . 9 )
93 0 0 3 1.0 (+/-1.7) 0 0 0 0 (+/-0)
53 2 0 0 0.7 (+/-1.2) 0 0 0 0 (+/-0)
47 0 0 1 0.3 (+/-0.6) 0 0 50 16.7 (+/-28.9)
44 0 0 1 0.3 (+/-0.6) 0 0 0 0 (+/-0)
49 1 0 0 0.3 (+/-0.6) 2 1 0 0.7 (+/-0.8)
107 1 0 0 0.3 (+/-0.6) 1 0 0 0.3 (+/-0.5)
2 0100 . 3 ( + / - 0 . 6 )100 0 . 3 ( + / - 0 . 5 )
51 0 1 0 0.3 (+/-0.6) 1 0 0 0.3 (+/-0.5)
17 0 1 0 0.3 (+/-0.6) 0 0 0 0 (+/-0)
30 0 1 0 0.3 (+/-0.6) 0 0 0 0 (+/-0)
41 0 1 0 0.3 (+/-0.6) 0 0 0 0 (+/-0)
42 0 1 0 0.3 (+/-0.6) 0 0 0 0 (+/-0)
8 4 0000 ( + / - 0 ) 002 0 . 7 ( + / - 1 . 2 )
5 0000 ( + / - 0 ) 010 0 . 4 ( + / - 0 . 8 )
Table 2: Comparison of array based clonotyping to cloning and 
sequencing of PCR products: Subject A
Array analysis Cloning/sequencing
Clono
type
123M e a n ( S D ) 1 23 M e a n( S D )
50 3
8
1
1
2
7
25.4 (+/-
13.6)
20 0 0 6.7 (+/-11.5)
41 2 1
6
3
2
16.5 (+/-
14.8)
20 2
7
40 28.9 (+/-10.2)
51 1
2
3
7
0 16.3 (+/-
18.7)
10 4
0
0 16.7 (+/-20.8)
5 8 831
6
9.0 (+/-6.3) 0 0 0 0 (+/-0)
4 6845 . 7 ( + / - 2 . 1 ) 1 070 5 . 6 ( + / - 5 . 1 )
4 8 7074 . 7 ( + / - 4 . 1 ) 1 002 71 2 . 2 ( + / - 1 3 . 5 )
4 2 6704 . 1 ( + / - 3 . 6 ) 1 01
3
0 7.8 (+/-6.9)
1 3 2803 . 3 ( + / - 4 . 0 ) 0 07 2 . 2 ( + / - 3 . 8 )
8 3243 . 1 ( + / - 0 . 8 ) 0 70 2 . 2 ( + / - 3 . 8 )
5 0092 . 8 ( + / - 4 . 9 ) 0 02 78 . 9 ( + / - 1 5 . 4 )
1 8002 . 6 ( + / - 4 . 5 ) 2 000 6 . 7 ( + / - 1 1 . 5 )
3 6001 . 9 ( + / - 3 . 2 ) 0 00 0 ( + / - 0 )
9 0 0401 . 5 ( + / - 2 . 6 ) 0 00 0 ( + / - 0 )
8 2 1111 . 0 ( + / - 0 ) 0 00 0 ( + / - 0 )
1 7 0010 . 4 ( + / - 0 . 7 ) 0 00 0 ( + / - 0 )
7 4 1000 . 4 ( + / - 0 . 6 ) 0 00 0 ( + / - 0 )
4 9 0100 . 4 ( + / - 0 . 6 ) 0 00 0 ( + / - 0 )
5 2 0100 . 4 ( + / - 0 . 6 ) 0 00 0 ( + / - 0 )
7 5 0100 . 4 ( + / - 0 . 6 ) 0 00 0 ( + / - 0 )
9 1 0000 . 0 ( + / - 0 ) 0 70 2 . 2 ( + / - 3 . 8 )BMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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application each of the 108 CDR3β-specific probes meas-
ure the contribution of individual clonotypes within a sin-
gle sample to define the T-cell repertoire. In order for the
repertoire to be accurately measured, it is paramount to
control any array fabrication and/or oligonucleotide
probe variables that might lead to erroneously high or low
signal intensities at any given address on the array. The
susceptibility of spotted microarrays to fabrication-based
quality control issues is well documented [19-22]. When
array imaging is conducted with confocal laser scanners
possessing narrow bandwidths, fluorescein is compatible
with the commonly used cyanine dyes. Thus, we typically
tag cDNA probes during amplification using fluorescein-
labeled oligonucleotide primers [23,24]. However, fluo-
rescently modifying oligonucleotide probe sets is cost pro-
hibitive, therefore, we co-spot a fluorescein-labeled
"tracking" oligonucleotide at low molarity with the target-
specific probes [15] when printing oligonucleotide arrays.
In either case, labeling the array with a third fluorophore,
enables array quality control prior to hybridization of
potentially precious samples to substandard arrays.
As useful as the tracking oligonucleotide is, it is not fully
informative in controlling oligonucleotide synthesis. The
novel dual specificity probe design described here pos-
sesses a 5'-region specific for the A. thaliana LTP4 gene
intended to facilitate evaluation of probe synthesis. This
region is synthesized after the 3' CDR3β-specific region,
thus as shown in Figure 2A, a single hybridization with A.
thaliana LTP4 synthetic target can provide control of oligo-
nucleotide synthesis for the entire probe set. Thus, using
the A. thaliana LTP4 signal intensity it is possible to show
relative equality of the probes across the array, a necessary
prerequisite to specificity testing of each probe with the
synthetic targets. An unexplored and more costly alterna-
tive to ensure immobilization of full-length probes would
be to print 5' amine modified oligonucleotides onto slides
coated with N-hydroxysuccinimide (NHS) ester reactive
groups. We have also empirically determined that the 63-
mer probe design yields better signal intensities upon
hybridization of synthetic targets compared to 17-mer
probes encompassing only the CDR3β, despite the high
surface density that can be achieved by printing the short
probe (data not shown). This effect is attributable to the
possibility that labeled target molecules may have less
steric interference and greater access to the longer probes
[25-27]. Thus, our probe design provides a means of syn-
thesis quality control, possesses a short CDR3β-specific
region for high specificity, yet is of sufficient length to gen-
erate robust hybridization signals.
In typical array-based gene expression or genotyping
applications, it is desirable that all the probes on the array
possess similar hybridization characteristics, however,
minor performance differences are tolerable since com-
parisons of different samples are made across a single
probe. In this application, single samples are quantita-
tively analyzed over multiple probes, making it necessary
to account for differences in probe efficiencies. Having
quantified the performance of probes for the 108 IRSS
encoding CDR3β clonotypes it is theoretically possible to
mathematically correct differences in hybridization effi-
ciency. In practice we found that this approach is cumber-
some. Although the array performs in a predictable
manner, the exact degree of correction for each probe is
dependent on experimental conditions and array fabrica-
tion. Thus, proper mathematical correction would require
implementing sophisticated algorithms to correct for the
inter-experiment differences. This is neither realistic nor
convenient. In view of the situation, we have instead
designed a practical approach that employs hybridization
Table 4: Comparison of array based clonotyping to cloning and 
sequencing of PCR products: Subject C
Array analysis Cloning/sequencing
Clono
type
1 2 3 Mean (SD) 1 2 3 Mean (SD)
50 9 2
3
1
6
16.1 (+/-7.1) 4 1 0 1.5 (+/-1.8)
70 2
6
1
2
0 12.6 (+/-
12.9)
6
1
20 2 0 . 9 ( + / -
34.5)
51 1
9
148 . 1 ( + / - 9 . 5 )2
1
09 1 0 . 0 ( + / -
10.8)
21
1
1
1
0 7.3 (+/-6.3) 1
0
3
3
57 33.1 (+/-
23.5)
80 2
1
07 . 0 ( + / -
12.1)
05
6
0 18.7 (+/-
32.4)
6 0 501
1
5.3 (+/-5.5) 0 0 0 0 (+/-0)
2 0 001
4
4.8 (+/-8.2) 0 0 0 0 (+/-0)
6 3253 . 5 ( + / - 1 . 8 )022 27 . 9 ( + / -
12.0)
5 8 0283 . 2 ( + / - 4 . 0 )000 0 ( + / - 0 )
4 7 3052 . 8 ( + / - 2 . 8 )000 0 ( + / - 0 )
8 8 0082 . 6 ( + / - 4 . 4 )000 0 ( + / - 0 )
1 0 6 0172 . 5 ( + / - 3 . 6 )000 0 ( + / - 0 )
1 8 0702 . 3 ( + / - 4 . 0 )000 0 ( + / - 0 )
7 1 2132 . 1 ( + / - 1 . 2 )000 0 ( + / - 0 )
8 2 0051 . 8 ( + / - 3 . 2 )000 0 ( + / - 0 )
6 1 0141 . 8 ( + / - 2 . 3 )000 0 ( + / - 0 )
8 6 0501 . 7 ( + / - 2 . 9 )000 0 ( + / - 0 )
7 2301 . 7 ( + / - 1 . 5 )000 0 ( + / - 0 )
9 4 0041 . 5 ( + / - 2 . 5 )000 0 ( + / - 0 )
2 1 0401 . 3 ( + / - 2 . 3 )000 0 ( + / - 0 )
4 9 4001 . 3 ( + / - 2 . 3 )000 0 ( + / - 0 )
2 6 4001 . 3 ( + / - 2 . 3 )000 0 ( + / - 0 )
4 2 4001 . 3 ( + / - 2 . 3 )000 0 ( + / - 0 )
6 7 4001 . 3 ( + / - 2 . 3 )000 0 ( + / - 0 )
7 4 0031 . 1 ( + / - 1 . 9 )000 0 ( + / - 0 )
5 2 0301 . 0 ( + / - 1 . 7 )010 0 . 3 ( + / - 0 . 5 )
8 4 0301 . 0 ( + / - 1 . 7 )000 0 ( + / - 0 )
7 5 3001 . 0 ( + / - 1 . 7 )000 0 ( + / - 0 )
5 5 2000 . 7 ( + / - 1 . 1 )000 0 ( + / - 0 )
1 0000 ( + / - 0 ) 441 05 . 7 ( + / - 3 . 5 )
2 3 0000 ( + / - 0 ) 002 0 . 7 ( + / - 1 . 3 )
6 9 0000 ( + / - 0 ) 100 0 . 4 ( + / - 0 . 7 )
9 0 0000 ( + / - 0 ) 001 0 . 4 ( + / - 0 . 6 )
4 0000 ( + / - 0 ) 010 0 . 3 ( + / - 0 . 5 )BMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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of the equimolar mixture Cy3-labeled synthetic targets to
allow normalization of differences in hybridization effi-
ciencies between probes.
Spectratyping and clonotyping have been the mainstays of
analyzing TCR diversity for over a decade, however, in
addition to the strategy described here, other array-based
strategies have been employed. Ogle et al., [28] directly
measured lymphocyte receptor diversity by utilizing the
cross-hybridization patterns of T or B cell transcripts to
Affymetrix GeneChips. More recently, Bonarius et al., [29]
interrogated TCR diversity by first hybridizing CDR3-spe-
cific "annealers" to amplified product, which in turn were
ligated to a random hexamer array. While this elegant
approach provides a measurement of the overall T-cell
repertoire, it has not been shown able to quantitatively
resolve clonotypes differing by a single nucleotide.
Conclusion
We have validated this new array strategy through recon-
stitution studies, using known mixtures of synthetic target
(Figure 4), as well as through comparison to traditional
cloning and sequencing of VB17-JB2.7 PCR product
(Tables 2, 3, 4). These studies show that array-based
clonotyping is a reliable, efficient, and cost effective
approach that is at least as informative as traditional
clonotyping. While unmodified 63-mer probes are very
affordable, the set of labeled synthetic targets for normal-
ization are relatively expensive. However, the reagent
costs required to set up this type of array-based genotyp-
ing system can be distributed over thousands of analyses.
Thus, in terms of both materials and labor, the cost of
clonotyping by array is less that than cloning and
sequencing. The array based method is also more direct in
that there are fewer steps between RT-PCR and data acqui-
sition, thus exhaustive cloning and its potential biases are
avoided. As with any genotyping assay, one must have
knowledge of the sequences being assayed, therefore a
practical limitation of the approach is the requirement for
a priori knowledge of the TCR usage of the T-cell response
under analysis. Once this has been established, the array
based approach allows for much higher through-put mak-
ing more feasible population based studies of the human
immune response to influenza A. These efforts lay the
foundation for expanding the clonotyping array to cover
additional motifs, including those VB17-JB2.7 rearrange-
ments encoding IRSA, VRSS, MRSA, and SRSS, relevant to
monitoring memory responses to influenza A. The
approach used here is broadly applicable to situations
where complex mixtures of highly homologous sequences
need to be quantitatively resolved. Examples of such
applications include HLA typing, viral or bacterial geno-
typing and characterization microbial species within envi-
ronmental samples.
Methods
Oligonucleotide probes and synthetic targets
Oligonucleotide probes (63-mers) specific for 108 differ-
ent CDR3 motifs encoding the core amino acids IRSS were
designed with the assistance of the Oligo 6.0 software
(Molecular Biology Insights, Inc., Cascade, CO) (Table 1).
Probe sequences were evaluated for dimer formation,
interfering secondary structure, GC content and melting
temperature. The probes were designed with a 23 nucle-
otide 5'-region specific for the A. thaliana LTP4 (lipid
transfer protein 4) gene; a 23 nucleotide polyA spacer, and
a 17 nucleotide IRSS-specific region (sense strand) placed
at the 3'-end of the probe.
Synthetic targets consisted of set of 108 5'-Cy3-labeled 73-
mers (anti-sense strand, Table 1). These positive controls
were necessary for testing probe specificity as well as for
normalization. They precisely mimic the 73 bp RT-PCR
product generated by the BV17 and BJ2.7-specific oligo-
nucleotide primers used for clonotyping. All probes and
synthetic targets were supplied by Integrated DNA Tech-
nologies (Coralville, IA) and their concentrations were
measured on a UV spectrophotometer (SpectraMax Plus
384, Molecular Devices, Sunnyvale, CA).
Array fabrication
Oligonucleotide probes were reconstituted at a final con-
centration of 40 µM in printing buffer (1.5 M betaine, 3%
DMSO, 0.5 uM tracking oligonucleotide). As previously
described [15], the tracking oligonucleotide [5'-(FITC)-
ATGAAGAAACTATATACATCTTATGGCACTTATGGATTTT
TACATCAGATAAAAATCAATAACCCGACCC-3'], based
upon the Staphylococcus aureus response regulator trap, is
fluorescein-tagged and co-spotted at a 1:80 molar disad-
vantage relative to target-specific oligonucleotides. The
tracking oligonucleotide does not interfere with the
hybridization of targets to target-specific probes, but ena-
bles array visualization and quality control prior to
hybridization [15].
The oligonucleotide probes were printed onto poly-L-
lysine coated slides using a GeneMachines Omnigrid
arrayer (San Carlos, CA) and Telechem International
SMP3 pins (Sunnyvale, CA) at 40% humidity and 24°C.
To control pin contact force and duration, the instrument
was set with the following Z motion parameters, velocity:
7 cm/sec, acceleration: 100 cm/sec2, deceleration: 100
cm/sec2. After printing, oligonucleotides were UV cross-
linked to slides and processed using the previously
described nonaqueous blocking protocol [30]. Prehybrid-
ization fluorescein images were collected using a ScanAr-
ray 5000 (GSI Lumonics, Billerica, MA) to assess overall
printing fidelity and probe deposition. Nine replicate
arrays were printed on each glass slide.BMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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Generation of M158–66/HLA-A2.1-specific CD8 T-cell 
cultures
Influenza M158–66/HLA-A2.1-specific CD8 T-cell cultures
were generated by stimulating 2 × 106 cells at 1 × 106/1 ml
cell concentration, 1 uM M158–66 peptide final concentra-
tion, and 10 unit/ml human recombinant IL2, in a 13 ml
round bottom tube. The culture was carried for 2 weeks
with adding IL2 every 3 days and re-stimulating after the
first week. Re-stimulation used irradiated (3000 RAD)
autologous PBMC pulsed with peptide for 3 hours at a 1/
1 ratio with the cultured cells. Cultures typically possessed
approximately 5 × 105 cells at the end of two weeks. All
cultures were performed in triplicate.
RNA isolation, cDNA synthesis and spectratyping
RNA was isolated from cultured cells using Dynabeads
mRNA direct kit as instructed (Invitrogen, Carlsbad, CA)
and cDNA synthesis, CDR3β spectratyping, primer
sequences and electrophoretic conditions have been pre-
viously described [31]. Briefly, cDNA samples were ampli-
fied by PCR using VB17-specific forward primer and J-
specific carboxyfluorescein-labeled reverse primers for
30–32 cycles (non-saturating PCR reactions to minimize
possibility of changing distribution of sequences). 10 ul
of the amplified product was separated by electrophoresis
through 5 M urea/5% polyacrylamide sequencing gels.
Gels were imaged with a FluorImager 595 fluorescence
detection system (Molecular Dynamics, Piscataway, NJ).
The 150 base PCR fragment was cut out of the gel, DNA
was extracted from the gel piece using QIAEX II DNA
extraction kit as instructed (QIAgen, Valencia, CA), 10 ul
of the extracted DNA was re-amplified for 3 cycles in a 20
ul reaction using unlabelled constant primer. Ligation and
transformation was done using pCR4-TOPO kit (Invitro-
gen). Glycerol stocks of bacterial colonies were sequenced
by a commercial vendor (Genewiz, North Brunswick, NJ).
CDR3 junction sequences were identified and analyzed
using Finch TV (htpp://www.geospiza.com/finchtv/).
Analysis of VB17 and J region flanking sequences indi-
cated <0.5% divergence from the genomic sequences,
which can be attributed to reverse transcriptase and Ampl-
iTaq DNA polymerase infidelity. Only clonotypes con-
taining a VB17 CDR3 that were ten amino acid residues in
length were subject to statistical analysis.
Array sample and hybridization
VB17 repertoire analysis by microarray utilized the same
M1-specific CD8 T-cell cDNA samples described above.
One microliter of cDNA was amplified with unlabeled
VB17-specific forward [5'-CCAAAAGAAC-
CCGACAGCTTTC-3'] and Cy5 labeled J2.7-specific
reverse [5'-(Cy5)-CGGCCCGAAGTACTGCTCG-3'] prim-
ers in a 40 µl non-saturating PCR reaction using a com-
mercial PCR Master Mix (Promega, Madison, WI),
possessing 25 u/ml Taq, 200 µM dNTPs and 1.5 mM
MgCl2. Forward and reverse primers were added for a
final concentration of 0.25 µM. Thirty-two cycles of PCR
were performed (94°C, 30 seconds; 55°C, 30 seconds;
72°C, 30 seconds) in a Perkin-Elmer 9700 thermal cycler.
PCRs were terminated after a 7-minute extension at 72°C
and analyzed by 10% TBE gel electrophoresis to confirm
presence of a single robust 73 bp product. To each PCR
product, 10.9 µl IRSS normalizing synthetic target mix
was added. This consisted of an equimolar mix of all 108
synthetic targets at a final concentration of 0.1 µM each.
The labeled cDNA was purified with Centri-Sep columns
(Princeton Separations, Adelphia, NJ) and dried to com-
pletion. The sample was then reconstituted in 27 µl of
hybridization buffer (5.2× Denhardt's solution, 6.3× SSC,
0.5% SDS and 52% formamide), heated at 95°C for 2
minutes and centrifuged for 6 minutes at 14,000 rpm.
Twenty-three microliters of sample was applied to the
array and covered with a glass cover slip. The array was
loaded into a Corning hybridization chamber and incu-
bated at 42°C for 16–18 hours. The cover slips were
removed by briefly immersing the arrays in 2× SSC and
0.1% SDS. The arrays were then washed in 2× SSC, 1×
SSC, 0.2× SSC and 0.05× SSC for 4 minutes, 1.5 minutes,
1.5 minutes and 10 seconds respectively. The slides were
spun dry at 100 rfu for 10 minutes at room temperature.
Cy3, Cy5 and FITC image files were generated by analyz-
ing the arrays with a ScanArray 5000 (GSI Luminonics,
Billerica, MA) confocal laser scanner.
Microarray data acquisition, filtering, and analysis
Array images were processed, analyzed, and subjected to
quality-dependent filtering using the Matarray software as
previously described [32,33]. The analysis first involved
measurement of the "unknown sample" signal intensity
for each probe. In the case of human T-cell culture sam-
ples, this was measurement of the Cy5 signal intensity
derived from the hybridized CDR3β RT-PCR product. In
the case of "reconstituted unknown samples" this was
measurement of Cy3 signal intensity derived from known
mixtures of synthetic targets. Signal intensities for the
equimolar mix of 108 synthetic targets was also deter-
mined. This allowed for normalization of the hybridiza-
tion efficiency differences between different CDR3β
sequences and their corresponding probes, thereby mak-
ing it possible to determine the relative abundances of the
different clonotypes within the sample. When conducting
reconstitution experiments with oligonucleotide mix-
tures, the unknown and equimolar normalizing mix were
hybridized to separate arrays since they both utilized the
same fluorochrome (Cy3). When analyzing human sub-
ject samples, the unknown and normalizing synthetic tar-
get mix were cohybridized since they were tagged with
different cyanine dyes, Cy5 and Cy3, respectively.BMC Genomics 2007, 8:329 http://www.biomedcentral.com/1471-2164/8/329
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Each analysis was conducted on duplicate glass slides,
since each slide possessed 9 arrays, a total of 18 replicates
were performed. After raw signal intensity values were col-
lected, the mean and CV (coefficient of variance) were
determined for CDR3β and normalizer signals for each of
the 108 probes. Data points possessing a quality score of
qcom = 0 were discarded. These primarily arose from signals
that were not resolvable from background noise. For
probes where the CV exceeded the median of all 108 CVs
+ 2SD (standard deviations), the 2 most outlying data
points were discarded and the mean and CV were recalcu-
lated. The normalized ratio for each of the 108 probes was
then determined by dividing the CDR3β signal intensity
by the normalizer signal intensity for each probe, as fol-
lows:
Normalized log10 Ratio = log10 CDR3β (probe 1–108) – 
log10 normalizer (probe 1–108) (2)
In any single sample, the majority of possible sequences
were not present. When analyzing the normalized inten-
sity data as a log ratio distribution, 2 subgroups were evi-
dent. One group, typically consisted of approximately
80% of the probes; these exhibited very low basal level
intensity. In contrast, the other group possessed signifi-
cantly higher intensity, which often, as expected [13,14],
exhibited a power-law distribution. For analysis, this
group was defined as those probes exhibiting intensities
greater than 2SD above the mean intensity of all probes.
Thus, to determine the relative abundances of the differ-
ent CDR3β sequences present in the sample, group 1
probe normalized intensities were set to 0. The normal-
ized intensities of the second group were divided by their
sum so that each CDR3β signal could be expressed as a
percentage of the total.
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